{{Rsnum
|rsid=6421571
|Chromosome=11
|position=118873063
|Orientation=plus
|GMAF=0.1722
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 63.4 | 34.8 | 1.8
| HCB | 75.7 | 20.6 | 3.7
| JPT | 83.2 | 14.2 | 2.7
| YRI | 59.9 | 31.3 | 8.8
| ASW | 56.1 | 40.4 | 3.5
| CHB | 75.7 | 20.6 | 3.7
| CHD | 67.6 | 30.6 | 1.9
| GIH | 70.3 | 27.7 | 2.0
| LWK | 57.3 | 35.5 | 7.3
| MEX | 73.7 | 22.8 | 3.5
| MKK | 56.8 | 35.5 | 7.7
| TSI | 73.5 | 24.5 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21399635
|Trait=None
|Title=Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis
|RiskAllele=C
|Pval=3E-12
|OR=1.3700
|ORtxt=[1.25-1.50]
|OA=1
}}

{{PMID Auto
|PMID=22707196
|Title=C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma.
}}

{{PMID Auto
|PMID=24833093
|Title=C-X-C chemokine receptor type 5 gene polymorphism affects gene expression in CD4+ T cells and is associated with increased risk of colorectal cancer
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}